Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

395
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
395
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.1K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.1K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

947
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
947
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

3.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
3.5K
Lipid Absorption01:24

Lipid Absorption

1.9K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
1.9K
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

365
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
365

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Yearly attained adherence to Mediterranean diet, estimated trajectories of lipid profile from 60 to 80 years, and onset of clinical dyslipidemias in older adults at high cardiovascular risk.

Lipids in health and disease·2026
Same author

Effect of Dapagliflozin on Myocardial Fibrosis After STEMI: A Double-Blind, Placebo-Controlled Randomized Trial.

Journal of clinical medicine·2026
Same author

Cardiovascular risk equations in type 1 diabetes: from generic models to personalized prediction.

Annals of medicine·2026
Same author

Metabolomic profiling in phenylketonuria: a systematic review of human studies.

Metabolomics : Official journal of the Metabolomic Society·2026
Same author

Pilot study evaluating a clinical decision support tool: "Virtual Lipidologist HTE-DLP 3.0".

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis·2026
Same author

Development of a blood-based lipidomic fat quality score for the risk of ischemic stroke.

European stroke journal·2026
Same journal

The Mediterranean diet is about much more than just food: how, with whom and when you eat are just as important for your health as what and how much you eat.

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis·2026
Same journal

Cardiovascular risk and metabolomic profile in adolescents: A comparative study between anorexia nervosa, normal weight, and obesity.

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis·2026
Same journal

Lipid profile and angiogenic markers in the detection of preeclampsia: The RECLAMA study.

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis·2026
Same journal

LDL cholesterol control in patients with atherosclerotic carotid stenosis>50%, previous endarterectomy or carotid stent.

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis·2026
Same journal

Lipid lowering therapy in Tangier disease: what is the best association?

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis·2026
Same journal

Inclisiran for LDL-C reduction in secondary prevention: Real-world evidence from a homogeneous Spanish cohort with subgroup insights.

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis·2026
See all related articles

Related Experiment Video

Updated: Nov 5, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.3K

Secondary hypertriglyceridemia.

Clara Viñals1, Daniel Zambón2, Gema Yago1

  • 1Servicio Endocrinología y Nutrición, Hospital Clínic de Barcelona, Barcelona, España.

Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis
|May 19, 2021
PubMed
Summary
This summary is machine-generated.

Secondary hypertriglyceridemia (HTG) is often caused by external factors. Identifying and managing these secondary causes, such as diet and medications, is crucial for effective HTG treatment.

Keywords:
Hipertrigliceridemia secundariaLipoproteínas de muy baja densidadMetabolic syndromeSecondary hypertriglyceridemiaSíndrome metabólicoVery low-density lipoprotein

More Related Videos

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

7.9K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.8K

Related Experiment Videos

Last Updated: Nov 5, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.3K
Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

7.9K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.8K

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Pharmacology

Background:

  • Secondary hypertriglyceridemia (HTG) is a prevalent condition characterized by elevated triglyceride-rich lipoproteins in plasma.
  • Identifying secondary causes of HTG is essential as they can exacerbate genetic predispositions.
  • Common secondary causes include lifestyle factors, metabolic diseases, and certain medications.

Purpose of the Study:

  • To highlight the significance of identifying and addressing secondary causes of hypertriglyceridemia.
  • To provide a comprehensive overview of the diverse factors contributing to secondary HTG.
  • To emphasize the role of managing secondary causes in the overall treatment strategy for HTG.

Main Methods:

  • Literature review of common and less frequent causes of secondary hypertriglyceridemia.
  • Analysis of the impact of various medical conditions and medications on triglyceride levels.
  • Categorization of secondary causes based on frequency and clinical significance.

Main Results:

  • Dietary factors (high fat, high glycemic index), obesity, diabetes mellitus, and alcohol consumption are frequent contributors to secondary HTG.
  • Medications such as oestrogen, isotretinoin, immunosuppressants, and L-asparaginase significantly influence HTG.
  • Less common causes include endocrinopathies (Cushing's syndrome, hypothyroidism), pregnancy, lipodystrophies, and autoimmune diseases.

Conclusions:

  • The identification and management or correction of secondary causes are fundamental to treating hypertriglyceridemia.
  • A thorough clinical evaluation to rule out secondary factors is a critical first step in managing HTG.
  • Addressing secondary contributors can significantly improve triglyceride levels and reduce cardiovascular risk.